Question explored with the scientific record
Does docusate work better than placebo for constipation in controlled trials?
The retrieved evidence does not include a single placebo-controlled trial of docusate for constipation.
The only study that mentions docusate is a 2017 quality-improvement project in Alberta Health Services [1]. It showed that after staff were told docusate lacks efficacy, its use dropped by about 55% over 18 months without increasing other laxatives [1]. That is not a controlled trial—it is a pre-post audit. It tells you what clinicians believed, not whether docusate works.
Every other record in this retrieval tests a different intervention: probiotics, lubiprostone, lactulose, prune juice, vibrating capsules, and others [2, 3]. None of them compare docusate to placebo. The question asks about controlled trials of docusate specifically, and this search found none.
Outside this retrieval, the broader literature is well-documented: multiple small randomized trials and systematic reviews have found docusate no better than placebo for stool frequency or consistency. But I cannot cite those numbers here because they are not in the evidence block. What the retrieval does show is that the one study mentioning docusate treated it as an ineffective drug worth deprescribing [1].
My call: the evidence retrieved does not support that docusate works better than placebo for constipation in controlled trials. The absence of such trials in this search is itself a finding. Confidence: low, because the retrieval is thin and the question deserves a direct trial comparison that was not found.
Sources used 3
-
Association of Dissemination of an Educational Communication Tool With Docusate Administration
A quality-improvement pre-post study in Alberta Health Services showed that disseminating an educational backgrounder about the lack of efficacy of docusate, along with webinars, markedly reduced docusate administration for constipation in inpatients and nursing-home residents o…
DOI: 10.1001/jamainternmed.2017.3605 -
Bacillus clausii UBBC-07 reduces severity of diarrhoea in children under 5 years of age: a double blind placebo controlled study
Bacillus clausii UBBC-07 spore suspension significantly shortened diarrhoea duration and reduced stool frequency in children aged 6 months to 5 years with acute diarrhoea, compared with placebo.
DOI: 10.3920/bm2018.0094 -
Correlates of regular laxative use by frail elderly persons
This cross-sectional study of frail elderly residents in a long-term care facility identifies demographic, clinical, and pharmacological factors associated with regular laxative use, highlighting immobility, Parkinson’s disease, diabetes, and certain medications as key predictor…
DOI: 10.1016/s0002-9343(99)80228-9